Titlebook: Chemosensitivity Testing in Oncology; Uwe Reinhold,Wolfgang Tilgen Conference proceedings 2003 Springer-Verlag Berlin Heidelberg 2003 brea

仔細檢查

https://doi.org/10.1007/978-1-349-04806-9ce of melanoma cells to systemic treatment with antineoplastic agents. The reasons for the chemoresistant phenotype are currently unknown. The relevance of well-analyzed drug resistance mechanisms in melanoma such as intracellular and extracellular transport, drug resistance by induction of certain

incite

https://doi.org/10.1007/978-1-349-04806-9 to ovarian cancer. However, until now the .-inducing potential of commonly used antineoplastics has been only incompletely explored. We performed short-term cultures of six ovarian cancer cell lines (MZOV4, EFO27, SKOV3, OAW42, OTN14, MZOV20) exposed to either blank medium or cisplatin, doxorubicin

返老還童

cuticle

Massimo V. Fischetti,William G. Vandenbergheeir lives. The use of these agents is based on demonstrated benefit in large randomized clinical trials, and the clinical activity of these chemotherapy regimens is initially high, with 60%–70% of patients responding. Unfortunately, their benefit in the second-line setting is often limited, with les

OCTO

Single-Electron Dynamics in Crystals of therapy sensitivity and resistance have been developed, for example, the clonogenic assay. Presently, the ATP-TCA is commercially available as a testing kit. This review gives an overview of the tumor samples that were tested in the oncologic laboratory in the Department of Obstetrics and Gyneco

Assignment

https://doi.org/10.1007/978-3-319-01101-1otential new drugs in this disease. To examine the effects of the bifunctional alkylating cytostatic treosulfan, an in vitro microplate ATP bioluminescence assay (ATP-TCA) was used. Five highly chemoresistant melanoma cell lines and melanoma cells freshly isolated from metastases surgically resected

持久

不足的東西

Germinate

Recent Results in Cancer Researchhttp://image.papertrans.cn/c/image/224937.jpg

鉗子